The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

The Role of Abiraterone in Prostate Cancer

Charles Ryan, MD
Published Online:3:15 PM, Thu July 28, 2016

Charles J. Ryan, MD, professor of Clinical Medicine, Urology, Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, discusses the role of abiraterone acetate (Zytiga) in the treatment of patients with prostate cancer, and the questions that remain about its use.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.